SJS Investment Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51K Sell
66
-123
-65% -$94.2K 0.01% 378
2025
Q4
$146K Buy
189
+39
+26% +$26.5K 0.02% 164
2025
Q3
$84.3K Buy
+150
New +$84.8K 0.01% 203
2025
Q2
Sell
-2
Closed -$1.27K 1634
2025
Q1
$1.27K Sell
2
-1
-33% -$688 ﹤0.01% 915
2024
Q4
$2.14K Sell
3
-5
-63% -$4.2K ﹤0.01% 675
2024
Q3
$8.41K Hold
8
﹤0.01% 397
2024
Q2
$8.41K Hold
8
﹤0.01% 356
2024
Q1
$7.7K Hold
8
﹤0.01% 386
2023
Q4
$7.03K Sell
8
-3
-27% -$2.47K ﹤0.01% 336
2023
Q3
$9.05K Hold
11
﹤0.01% 296
2023
Q2
$7.91K Sell
11
-2
-15% -$1.54K ﹤0.01% 294
2023
Q1
$10.7K Buy
13
+1
+8% +$754 ﹤0.01% 282
2022
Q4
$8.66K Buy
12
+6
+100% +$4.43K ﹤0.01% 297
2022
Q3
$4K Buy
+6
New +$3.78K ﹤0.01% 362
2022
Q1
$18K Buy
+26
New +$16.4K 0.01% 314

Other funds holding REGN